News

JD Supra15h
Trump Administration Issues Wide-Ranging EO to Lower Drug Prices
President Donald Trump signed an Executive Order (EO) titled “Lowering Drug Prices by Once Again Putting Americans First,” outlining ...
STAT19h
Pharmalittle: We’re reading about a Novo challenge to Medicare talks, a scuttled FDA office, and more
Novo Nordisk argues Medicare should negotiate the price for six of its insulin products separately, though they contain the ...
FDA May Shift Routine Food Inspections to States
The FDA already contracts with 43 states and Puerto Rico to do some routine inspections. States have handled about one-third ...
STAT19h
FDA approves blockbuster Dupixent for chronic hives
The FDA had rejected the companies’ initial application in 2023, requesting additional data after the pharma firms reported ...
WHYY19h
Health insurers are struggling with the cost of weight-loss drugs, including in Philly
Independence Health Group, the parent company of Independence Blue Cross, spent $500 million last year to provide ...
From tariffs to Target, ex-Medtronic CEO Bill George’s advice amid uncertainty
Former Medtronic chief executive and Harvard Business School executive fellow Bill George calls these times for corporate ...
Regeneron Pharmaceuticals, Inc.: Regeneron Provides Update on EYLEA HD (aflibercept) Injection 8 mg Supplemental Biologics License Application
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter ...